Diverticular Disease
Diverticular Disease
References
- The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis — Diseases of the Colon & Rectum, American Society of Colon and Rectal Surgeons (Hall J, Hardiman K, Lee S, et al.). Dis Colon Rectum 2020;63(6):728-747
- ACG Clinical Guideline: Colonic Diverticulitis — American Journal of Gastroenterology, American College of Gastroenterology (Peery AF, Strate LL, Stollman N, Mankaney G, Chang JW, Grover S). Am J Gastroenterol 2026;121(7):1549-1561
- 2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting — World Journal of Emergency Surgery, World Society of Emergency Surgery (Sartelli M, Weber DG, Kluger Y, et al.). World J Emerg Surg 2020;15:32
- Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline — American Journal of Gastroenterology, American College of Gastroenterology (Sengupta N, Feuerstein JD, Jairath V, Shergill AK, Strate LL, Wong RJ, Wan D). Am J Gastroenterol 2023;118(2):208-231
- Nut, corn, and popcorn consumption and the incidence of diverticular disease — JAMA (Strate LL, Liu YL, Syngal S, et al.). JAMA 2008;300(8):907-914
Clinical Snapshot
Diverticular disease spans a spectrum from silent, incidentally found diverticulosis to acute diverticulitis and diverticular bleeding. Diverticula are saclike outpouchings of colonic mucosa and submucosa that herniate through weak points in the muscular wall — most often in the sigmoid colon — and become more common with advancing age.[1] Most diverticulosis is entirely asymptomatic and needs no treatment at all; the clinical and pharmacotherapy work centers on the minority who develop acute diverticulitis (an inflammatory process, only sometimes truly infectious, that is either uncomplicated or complicated by an abscess, free perforation, a fistula, or an obstruction), chronic or recurrent symptoms, or an unrelated but equally important complication — diverticular bleeding, which arises from the same outpouchings through a completely different mechanism and is managed as its own distinct presentation, not as a variant of diverticulitis.[2] The dominant recent shift in management is away from routine antibiotics for uncomplicated diverticulitis and away from historical dietary restrictions that current evidence does not support.
Recognize the Condition
What a patient with diverticular disease reports depends entirely on which category is present — the categories below are not stages of one linear illness, and a patient can move between some of them (recovered diverticulitis reverting to asymptomatic diverticulosis) but not others (asymptomatic diverticulosis does not progress into diverticular bleeding, which is a separate vascular event).[2]
The categories of diverticular disease
Asymptomatic diverticulosis
Found incidentally on colonoscopy or cross-sectional imaging performed for another reason. No symptoms are attributable to the diverticula themselves, and no treatment is indicated beyond general prevention counselling.
Symptomatic uncomplicated diverticular disease (SUDD)
Recurrent left lower quadrant abdominal pain, bloating, and altered bowel habit that overlaps heavily with irritable bowel syndrome, without a proven episode of diverticulitis. Pain is often colicky and eased by passing flatus or having a bowel movement; onset at an older age and male sex are typical.
Acute uncomplicated diverticulitis
Constant left lower quadrant pain (right-sided disease is possible but far less common), often with low-grade fever, nausea, and a change in bowel habit. Bladder irritation from an adjacent inflamed sigmoid colon can cause urinary frequency or dysuria without true infection. No abscess, free perforation, fistula, or obstruction on imaging.
Acute complicated diverticulitis
The same picture plus an abscess, free/uncontained perforation, fistula, obstruction, or stricture on imaging. A colovesical fistula causes pneumaturia, fecaluria, or recurrent polymicrobial urinary tract infection; a colovaginal fistula causes stool or gas passed vaginally. Fever, tachycardia, hypotension, or diffuse (rather than localized) peritoneal signs point toward more severe disease.
Chronic recurrent diverticulitis and segmental colitis associated with diverticulosis (SCAD)
Chronic recurrent diverticulitis is repeated discrete acute attacks. SCAD is a distinct chronic inflammatory pattern confined to the diverticulosis-bearing segment, presenting with chronic diarrhea, cramping, and sometimes intermittent hematochezia rather than discrete attacks.
Diverticular bleeding
Sudden, painless, often large-volume hematochezia or maroon stool, frequently in a patient with no history of diverticulitis at all. This is erosion of a vasa rectum at the dome or neck of a diverticulum — an entirely different mechanism from the inflammatory process that causes diverticulitis — and it is managed as a distinct acute GI bleed, not as diverticulitis.
Risk Factors
- Advancing age — both prevalence and complication risk increase with age.
- A diet low in fibre and high in red meat, refined grains, and processed foods.
- Obesity and a higher body mass index.
- Physical inactivity — low vigorous activity is independently associated with diverticulitis.
- Current or former smoking.
- Regular non-aspirin NSAID or opioid analgesic use — associated with increased risk of diverticulitis, perforation, and diverticular bleeding.
- Family history of diverticular disease.
- Connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome) and polycystic kidney disease — associated with earlier-onset and right-sided disease.
- Immunosuppression — transplant recipients, chronic corticosteroid use, and chemotherapy all increase the risk of complicated disease and can blunt the usual clinical signs.
- Chronic kidney disease, particularly dialysis dependence — associated with more severe presentations.
Tobacco cessation, reduced meat intake, regular physical activity, and weight loss are the modifiable factors worth addressing directly with every patient — see Non-Pharmacologic Treatment.[1]
Red Flags & Refer
Any of the following in a patient with suspected diverticular disease needs urgent escalation rather than routine outpatient management.[1]
- Diffuse abdominal peritonism — rigidity, involuntary guarding, or rebound tenderness — suggesting free perforation with peritonitis.
- Sepsis or hemodynamic instability (hypotension, tachycardia out of proportion to pain, altered mentation).
- Large-volume or ongoing lower GI bleeding, or any hematochezia with hemodynamic compromise.
- Bowel obstruction — obstipation, marked distension, persistent vomiting.
- Signs of fistula — pneumaturia, fecaluria, recurrent polymicrobial urinary tract infection (colovesical), or stool or gas passed vaginally (colovaginal).
- Failure to improve, or clinical worsening, within 48-72 hours of appropriate outpatient or inpatient therapy.
- Any immunocompromised patient with suspected diverticulitis — treat as high-risk/complicated regardless of how mild the initial presentation looks, and involve surgery early, since peritoneal signs and fever can be blunted while disease still progresses.
- A pregnant patient with suspected diverticulitis — involve obstetrics and general surgery/gastroenterology urgently in addition to the standard workup.
Assessment & Diagnosis
History
- Characterize the pain — location (classically left lower quadrant), constancy, duration before presentation, and any prior similar episodes.
- Ask specifically about fever, nausea/vomiting, and change in bowel habit (constipation or diarrhea).
- Ask specifically about urinary symptoms (bladder irritation versus true fistula symptoms — pneumaturia, fecaluria) and, in women, vaginal passage of stool or gas.
- Review prior colonoscopy and imaging results, family history of colorectal cancer or diverticular disease, smoking status, and regular NSAID, opioid, or immunosuppressant use.
- Confirm pregnancy status in anyone of childbearing potential before selecting imaging.
Differential diagnosis to consider
Diverticulitis is not the only cause of this presentation — actively consider appendicitis (especially with right-sided pain), an inflammatory bowel disease flare, ischemic colitis, irritable bowel syndrome, gynecologic causes (ovarian torsion or cyst, pelvic inflammatory disease, ectopic pregnancy), urinary tract infection or nephrolithiasis, colorectal malignancy, and simple constipation.[1]
Physical examination
Left lower quadrant tenderness, sometimes with a palpable tender mass from a phlegmon or walled-off abscess. Assess specifically for fever and for diffuse peritoneal signs, which point toward complicated disease and change management immediately.
Laboratory tests
- CBC — leukocytosis is common but can be normal even in confirmed diverticulitis, so a normal white count does not rule it out.
- CRP — a useful adjunct marker of inflammatory burden, but no single validated cutoff reliably separates uncomplicated from complicated disease on its own; interpret alongside imaging and the clinical picture rather than as a standalone decision rule.
- Electrolytes and renal function — needed before selecting and dosing antibiotics, and before IV contrast.
- Urinalysis — sterile pyuria can occur from adjacent bladder inflammation; frank fecaluria suggests a colovesical fistula.
- Beta-hCG in anyone of childbearing potential.
- Stool studies (C. difficile, culture, ova and parasites) when diarrhea predominates or there has been recent antibiotic exposure.
Imaging
CT of the abdomen and pelvis with IV contrast is the standard imaging test for suspected diverticulitis — it confirms the diagnosis, stages severity, and identifies the abscess, perforation, fistula, or obstruction that changes management. Obtain it for a first episode and whenever a more severe presentation or diagnostic uncertainty is present; for a mild, classic recurrence in a patient with a prior imaging-confirmed episode, careful clinical reassessment without repeat CT can be reasonable.[2]
Ultrasound or MRI are reasonable alternatives when CT is unavailable or contraindicated — notably in pregnancy or a significant contrast allergy — though ultrasound is user-dependent and can miss complicated disease, so it should not be the only imaging used when complicated disease is suspected.[1]
Colonoscopy is deferred during the acute phase — the inflamed, friable bowel carries a real perforation risk — and is instead performed 6-8 weeks after recovery; see Monitoring & Follow-Up for exactly who needs it and when. Barium enema is no longer used given the same perforation-related contrast-extravasation risk, and a plain abdominal x-ray is not useful for diagnosing diverticulitis itself, though it can quickly identify free air or obstruction as an initial nonspecific test.
Staging complicated disease: the Hinchey classification
CT severity is described using the (modified) Hinchey classification, which stages complicated disease and guides the choice between antibiotics alone, percutaneous drainage, and emergency surgery — see Choose Initial Treatment and the Clinical Decision Algorithm.[3]
| Stage | Definition |
|---|---|
| Ia | Confined pericolic inflammation or phlegmon, without a discrete abscess. |
| Ib | Confined pericolic or mesocolic abscess. |
| II | Pelvic, distant intra-abdominal, or retroperitoneal abscess. |
| III | Generalized purulent peritonitis. |
| IV | Generalized feculent peritonitis. |
Treatment Targets
- Correctly distinguish uncomplicated from complicated disease — this single distinction drives essentially every downstream decision.
- In acute uncomplicated diverticulitis, achieve symptom improvement within 2-3 days and full resolution within 7-10 days, whether or not antibiotics are used.
- Achieve source control — percutaneous drainage or surgery — for any abscess, free perforation, fistula, or obstruction, rather than relying on antibiotics alone.
- Avoid antibiotic exposure that does not change outcomes in low-risk uncomplicated disease.
- Exclude an underlying or masquerading colorectal malignancy after any complicated episode, or any uncomplicated episode with alarm features.
- In SUDD and chronic/recurrent diverticulitis, reduce symptom frequency, improve quality of life, and prevent progression to diverticulitis or its complications.
- In diverticular bleeding, achieve hemodynamic stabilization and definitive hemostasis, and reduce rebleeding risk.
- Reduce long-term recurrence risk through sustained lifestyle modification — current evidence does not support a pharmacologic prevention strategy.[2]
Choose Initial Treatment
Asymptomatic diverticulosis found incidentally — no treatment is indicated; counsel on the same high-fibre, active-lifestyle measures recommended for prevention (see Non-Pharmacologic Treatment) and stop there.
Acute uncomplicated diverticulitis, low-risk — immunocompetent, tolerating oral intake, no significant comorbidity, and a reliable follow-up plan: manage as an outpatient without routine antibiotics, with clinical reassessment at 48-72 hours.[2]
Acute uncomplicated diverticulitis with a high-risk feature — use when the patient is immunocompromised, frail, has significant comorbidity, cannot tolerate oral intake, shows signs of systemic infection, or does not have a safe outpatient situation: start antibiotics (see Pharmacologic Treatment Options) for a 4-7 day course.[1]
Acute complicated diverticulitis (abscess, free perforation, fistula, or obstruction on CT) — always start antibiotics and pursue source control matched to the finding: antibiotics alone for a small abscess, percutaneous drainage for a larger one, and emergency surgery for diffuse peritonitis or failure of the above — see the Clinical Decision Algorithm for the exact branch points.
SUDD, chronic recurrent diverticulitis, and SCAD — a high-fibre diet and the lifestyle measures under Non-Pharmacologic Treatment are the mainstay; do not add mesalamine, rifaximin, or probiotics for symptom control or recurrence prevention, since current evidence does not support benefit from any of them.[2]
Diverticular bleeding — manage as its own acute GI bleed: hemodynamic resuscitation, risk stratification, and colonoscopy with endoscopic hemostasis if an active bleeding diverticulum is found — never as diverticulitis, and never with antibiotics.[4]
Non-Pharmacologic Treatment
- Recommend a high-fibre diet rich in fruits, vegetables, whole grains, and legumes — aim for at least 25-30 g of fibre per day — while limiting red meat, processed grains, and sweets; a fibre supplement can help reach this target but is not a substitute for dietary fibre.[2]
- Do not advise avoiding nuts, seeds, popcorn, or small-seeded fruits (e.g., strawberries, blueberries) — this historical restriction, based on the theory that these foods could lodge in a diverticulum, is not supported by current evidence, and current guidance specifically recommends against advising patients to avoid them.[5]
- Advise regular vigorous physical activity — low activity levels are independently associated with a higher risk of diverticulitis.
- Advise achieving and maintaining a healthy body mass index (18.5-24.9); higher BMI is independently associated with diverticulitis and its complications.
- Advise smoking cessation — smoking is associated with a higher risk of diverticular disease and of perforated disease specifically.
- Advise limiting non-aspirin NSAID use to when it is clinically necessary; continue low-dose aspirin taken for secondary cardiovascular prevention rather than stopping it reflexively.[2]
- Advise moderating alcohol intake.
- Pair any increase in dietary fibre with adequate fluid intake to avoid worsening bloating or constipation.
- After an episode of diverticular bleeding specifically, confirm the patient has stopped any non-aspirin NSAID going forward.[4]
Pharmacologic Treatment Options
| Drug / intervention | Role | Dose / use | Important adverse effects | Teaching points |
|---|---|---|---|---|
| Amoxicillin/clavulanate Preferred | First-line antibiotic when indicated for uncomplicated diverticulitis with a high-risk feature, or as part of complicated-disease therapy | 875 mg/125 mg PO BID for 4-7 days | Diarrhea, rash, rare cholestatic hepatitis | Single-agent monotherapy — the clavulanate component already covers anaerobes. Preferred choice in pregnancy when antibiotics are indicated. |
| Ciprofloxacin + metronidazole Alternative | Antibiotic combination when penicillin allergy or amoxicillin/clavulanate is not appropriate | Combo: ciprofloxacin 500 mg PO BID for 4-7 days + metronidazole 500 mg PO TID for 4-7 days | Tendinopathy, dizziness, QT prolongation, C. difficile-associated diarrhea | Reserve fluoroquinolones rather than defaulting to them, given tendon and QT risk. |
| Levofloxacin + metronidazole Alternative | Antibiotic combination when penicillin allergy or amoxicillin/clavulanate is not appropriate | Combo: levofloxacin 750 mg PO once daily for 4-7 days + metronidazole 500 mg PO TID for 4-7 days | Tendinopathy, dizziness, QT prolongation, C. difficile-associated diarrhea | Alternative fluoroquinolone partner; same stewardship reservations as ciprofloxacin. |
| Sulfamethoxazole/trimethoprim + metronidazole Alternative | Antibiotic combination when penicillin allergy and fluoroquinolone avoidance are both preferred | Combo: sulfamethoxazole/trimethoprim 800/160 mg PO BID for 4-7 days + metronidazole 500 mg PO TID for 4-7 days | Hyperkalemia, rash, nausea, rare Stevens-Johnson syndrome | Avoid in the first trimester and near term in pregnancy. |
| Piperacillin/tazobactam Special situation | Empiric IV therapy for hospitalized or complicated diverticulitis unable to tolerate oral intake | 3.375 g IV every 6 hours, per institutional protocol | Diarrhea, rash, hypokalemia, elevated transaminases | Single-agent IV option; transition to an oral regimen above once tolerating oral intake and clinically improving. |
| Mesalazine Avoid | Historically used for SUDD symptom control and recurrence prevention | Not currently recommended — see Drug Tables for historical dosing | Headache, abdominal pain, diarrhea, rare hypersensitivity reactions | Current evidence does not support benefit for SUDD or recurrence prevention — do not add for this indication. |
| Rifaximin Avoid | Historically studied for SUDD symptom control | Not currently recommended — see Drug Tables for historical dosing | Peripheral edema, dizziness, fatigue, nausea | Current guidance does not support use for SUDD or for prevention of recurrent diverticulitis. |
| Probiotics Avoid | Historically used for SUDD symptom control and recurrence prevention | Not standardized — formulation-dependent; see Drug Tables | Abdominal pain, bloating, diarrhea, constipation | Current guidance recommends against routine use given insufficient evidence of benefit. |
Special Populations
Pregnancy
Investigate and treat with the same urgency as a non-pregnant patient, with combined obstetric and general surgery/gastroenterology involvement. Prefer ultrasound or MRI over CT when feasible without compromising diagnostic accuracy in an urgent situation, but do not withhold CT if the clinical situation demands it and other modalities are non-diagnostic or unavailable. When antibiotics are indicated, amoxicillin/clavulanate is generally preferred; avoid fluoroquinolones (fetal/infant cartilage risk) and avoid sulfamethoxazole/trimethoprim in the first trimester (folate antagonism, neural tube defect risk — supplement folic acid if it must be used) and near term (neonatal hyperbilirubinemia risk). Metronidazole carries a low teratogenic risk and can be used when needed as part of a combination regimen.
Breastfeeding
Amoxicillin/clavulanate and metronidazole are compatible with breastfeeding at standard diverticulitis dosing. Avoid fluoroquinolones and sulfamethoxazole/trimethoprim while breastfeeding, particularly with a jaundiced, unwell, or G6PD-deficient infant.
Pediatrics
Diverticulitis is rare in children and, when it occurs, is more often right-sided with a different underlying pathophysiology than adult left-sided disease. Manage under pediatric gastroenterology/surgery direction rather than adult-pathway dosing.
Older adults
Older age combined with other markers of reduced physiologic reserve — poor functional status, multiple significant comorbidities, or laboratory evidence of renal or nutritional compromise — identifies patients at substantially higher risk with emergency surgery and should lower the threshold for imaging, admission, and early surgical involvement.[1]
Renal impairment
Dose-adjust ciprofloxacin, levofloxacin, sulfamethoxazole/trimethoprim, and metronidazole for reduced renal function; amoxicillin/clavulanate also requires adjustment in significant impairment. Confirm renal function before selecting and dosing any of these.
Immunocompromised patients
Transplant recipients, patients on chronic corticosteroids or chemotherapy, and other significantly immunocompromised patients should have any suspected diverticulitis treated as high-risk regardless of how mild the initial presentation or CT appears. Start antibiotics, involve surgery early, and keep a lower threshold for admission — peritoneal signs and fever are frequently blunted in this group while the underlying disease still progresses.
Chronic kidney disease
Dialysis-dependent chronic kidney disease is associated with more severe presentations and higher risk with emergency surgery — treat it as a marker for early specialist involvement, not just a dosing consideration.[1]
Monitoring & Follow-Up
- Reassess outpatient-managed uncomplicated diverticulitis clinically at 48-72 hours; expect improvement within 2-3 days and resolution within 7-10 days — escalate if the patient is not improving on this timeline.
- After a complicated episode, arrange colonoscopy 6-8 weeks after recovery to exclude malignancy and confirm the diagnosis, if a recent colonoscopy has not already done so.[2]
- After an uncomplicated episode, colonoscopy is only needed if the patient has alarm symptoms (unexplained weight loss, a genuine change in bowel habit, iron-deficiency anemia, rectal bleeding, persistent pain) or is not up to date with average-risk colorectal cancer screening.[2]
- Reinforce and reassess the lifestyle measures — fibre intake, weight, activity, smoking, NSAID use — at every follow-up; this is the actual long-term recurrence-prevention strategy, not a pharmacologic one.
- After diverticular bleeding, confirm non-aspirin NSAIDs have been stopped, and continue low-dose aspirin for secondary cardiovascular prevention and any indicated anticoagulation once hemostasis is secure, coordinated with the prescribing team.[4]
- Revisit the elective-surgery discussion for recurrent disease that is meaningfully affecting quality of life, or after a complicated episode involving fistula, obstruction, or stricture — this decision is individualized, never driven by episode count alone.[1]
Treatment Failure / Next Step
- No improvement, or worsening, within 48-72 hours of outpatient antibiotics/observation: reassess with repeat CT to look for an abscess, perforation, or an alternative diagnosis, and escalate to inpatient management.
- Abscess identified: image-guided percutaneous drainage for a stable patient with an abscess larger than 3 cm; antibiotics alone are usually adequate for a smaller abscess in a stable patient. If drainage is not technically feasible, or the patient does not improve after drainage, proceed to surgical consultation.[1]
- Diffuse peritonitis, uncontained perforation, or clinical deterioration despite antibiotics/drainage: urgent surgical consultation for sigmoid colectomy. In a hemodynamically unstable patient, one with feculent peritonitis, or one with major comorbidity, a Hartmann procedure (end colostomy) is preferred; in a stable patient with purulent peritonitis and no major comorbidity, primary resection with anastomosis (with or without a diverting loop ileostomy) is now generally preferred over a Hartmann procedure, given comparable mortality and better long-term stoma-free outcomes.[3]
- Diverticulitis complicated by fistula, obstruction, or stricture: refer for elective or semi-elective surgical resection once the acute inflammation has settled — antibiotics alone will not resolve any of these.[1]
- Persistent SUDD-type symptoms despite an adequate trial of a high-fibre diet and lifestyle measures: reconfirm the diagnosis (colonoscopy if not already done, reconsider irritable bowel syndrome or another overlapping diagnosis) rather than escalating to mesalamine, rifaximin, or probiotics — current evidence does not support any of them for this indication.[2]
- Recurrent diverticular bleeding, or bleeding that does not stop with endoscopic therapy: proceed to CT angiography with interventional radiology embolization, or surgery, if bleeding is refractory or the source cannot be localized and controlled.[4]
Common Errors to Avoid
- Reflexively prescribing antibiotics for every episode of uncomplicated diverticulitis — selective, not routine, use is now the evidence-based standard for a low-risk immunocompetent patient.
- Withholding antibiotics from a patient who actually has a high-risk feature — immunocompromise, significant comorbidity, frailty, systemic illness, or an unsafe outpatient situation — antibiotics remain indicated in these patients.
- Still telling patients to avoid nuts, seeds, popcorn, or small-seeded fruits — this restriction is outdated and current guidance specifically recommends against it.
- Prescribing mesalamine, rifaximin, or probiotics to prevent recurrent diverticulitis or to treat SUDD — current evidence does not support benefit from any of these.
- Performing or scheduling colonoscopy during the acutely inflamed phase of diverticulitis — wait 6-8 weeks given the perforation risk.
- Skipping the post-recovery colonoscopy after complicated diverticulitis — this population has a meaningfully increased chance of an underlying or masquerading malignancy.
- Recommending elective surgery based purely on the number of prior episodes rather than an individualized discussion of severity, quality of life, and patient preference.
- Treating diverticular bleeding as if it were diverticulitis — it is painless, does not need antibiotics, and needs a bleeding-specific workup instead.
- Continuing non-aspirin NSAIDs after a diverticular bleed, or after any episode of diverticulitis, without addressing this modifiable risk factor.
- Missing a colovesical or colovaginal fistula because pneumaturia, fecaluria, or vaginal passage of stool or gas was not specifically asked about.
Clinical Decision Algorithm
Drug Tables
How to use this table: Doses are adult doses and require patient-specific confirmation, including renal/hepatic adjustment. Antibiotics are indicated selectively, not routinely — see Choose Initial Treatment for exactly which patients need them. Select any drug name to open its complete Pharmasist Drug Database page.
Oral antibiotics for diverticulitis, when indicated
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Amoxicillin/clavulanate | Adults: 875 mg/125 mg PO BID for 4-7 days Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Diarrhea, nausea, skin rash, rare cholestatic hepatitis | None major; caution with other hepatotoxic drugs | Single-agent monotherapy — the clavulanate component covers anaerobes, so no metronidazole partner is needed. Preferred option in pregnancy when antibiotics are indicated. |
| Ciprofloxacin | Combo (adults): Ciprofloxacin 500 mg PO BID for 4-7 days + Metronidazole 500 mg PO TID for 4-7 days Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Tendinopathy/tendon rupture, dizziness, headache, QT prolongation, C. difficile-associated diarrhea | Chelation with divalent cations (calcium, iron, antacids) reduces absorption; additive QT risk with other QT-prolonging drugs | Always paired with metronidazole for anaerobic coverage — never used alone for diverticulitis. Reserve for penicillin allergy or when amoxicillin/clavulanate is not appropriate, given tendon and QT stewardship concerns with fluoroquinolones. |
| Levofloxacin | Combo (adults): Levofloxacin 750 mg PO once daily for 4-7 days + Metronidazole 500 mg PO TID for 4-7 days Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Tendinopathy/tendon rupture, dizziness, headache, QT prolongation, C. difficile-associated diarrhea | Chelation with divalent cations reduces absorption; additive QT risk with other QT-prolonging drugs | Alternative fluoroquinolone partner for metronidazole; same stewardship reservations as ciprofloxacin. |
| Sulfamethoxazole/trimethoprim | Combo (adults): Sulfamethoxazole/trimethoprim 800/160 mg (1 double-strength tablet) PO BID for 4-7 days + Metronidazole 500 mg PO TID for 4-7 days Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Nausea, rash, hyperkalemia, rare Stevens-Johnson syndrome/agranulocytosis | Increases INR with warfarin; hyperkalemia risk with ACE inhibitors/ARBs/potassium-sparing diuretics | Alternative for penicillin allergy or when fluoroquinolone avoidance is also preferred (e.g., a tendon disorder history). Avoid in the first trimester and near term in pregnancy. |
| Metronidazole | Adults: 500 mg PO TID for 4-7 days, as the anaerobic-coverage partner in a combination regimen (see ciprofloxacin, levofloxacin, and sulfamethoxazole/trimethoprim rows above) Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | GI upset, metallic taste, peripheral neuropathy with prolonged use, disulfiram-like reaction with alcohol | Avoid alcohol during treatment and for the interval stated in the product monograph; increases INR with warfarin | Provides the anaerobic coverage that amoxicillin/clavulanate already provides alone — do not add metronidazole to an amoxicillin/clavulanate regimen; it is always a combination-therapy partner for diverticulitis, never monotherapy. |
Empiric IV therapy for hospitalized or complicated disease unable to tolerate oral intake
Transition to an oral regimen above once tolerating oral intake and clinically improving.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Piperacillin/tazobactam | Adults (IV): 3.375 g IV every 6 hours, per institutional protocol; adjust for renal function Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Diarrhea, rash, hypokalemia, elevated transaminases | Increases INR with warfarin; caution with other nephrotoxic drugs | Single-agent empiric IV option for hospitalized or complicated diverticulitis. |
| Ceftriaxone | Combo (adults, IV): Ceftriaxone 1-2 g IV once daily + Metronidazole 500 mg IV every 8 hours Children: Not established for pediatric diverticulitis — this condition is rare and atypical (often right-sided) in children; manage under pediatric gastroenterology/surgery direction rather than adult dosing. | Diarrhea, rash, biliary sludging with prolonged use | Do not co-administer with IV calcium-containing solutions in neonates; increases INR with warfarin | Alternative empiric IV combination when piperacillin/tazobactam is not appropriate; always paired with IV metronidazole for anaerobic coverage. |
Agents not currently recommended for diverticular disease (included for reference)
Current guidance recommends against routine use of any of the following for SUDD symptom control or prevention of recurrent diverticulitis, given insufficient evidence of benefit.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Mesalazine (5-ASA) | Active disease (historical dosing): Up to 4.8 g/day PO in divided doses Maintenance (historical dosing): 1.6-3.2 g/day PO in divided doses | Headache, abdominal pain, diarrhea, nausea and vomiting, rash, rare hypersensitivity reactions (pneumonitis, hepatitis) | None major | Not currently recommended — included for reference only; mesalamine compounds are generally better tolerated than sulfasalazine when a 5-ASA agent is used for an unrelated indication. |
| Sulfasalazine | Active disease (historical dosing): 1-2 g PO 3-4 times daily Maintenance (historical dosing): 1 g PO 2-3 times daily | Nausea, vomiting, diarrhea, headache, hypersensitivity reaction, hemolytic anemia (particularly with G6PD deficiency), reversible oligospermia | None major; maintain adequate fluid intake to reduce crystalluria/stone-formation risk | Not currently recommended — included for reference only. |
| Rifaximin | Historical dosing: 550 mg PO BID (the only tablet strength available in Canada) | Peripheral edema, dizziness, fatigue, nausea, diarrhea | None major — minimal systemic absorption | Not currently recommended for SUDD or for prevention of recurrent diverticulitis — included for reference only. |
| Probiotics (e.g., Lactobacillus species) | Typical product example: Lactobacillus casei/Lactobacillus paracasei 750 mg PO daily — dosing is formulation-dependent and not standardized | Abdominal pain, bloating, diarrhea, constipation | None major | A heterogeneous class of natural health products with no single matching monograph. Not currently recommended for SUDD or for prevention of recurrent diverticulitis. |
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.